Erythropoietin Drug Market to Grow at 9.5% CAGR Between 2017 and 2023
Market Overview: Also known as hematopoietin, erythropoietin drug is defined as a glycoprotein hormone that controls erythropoiesis. Erythropoiesis is defined as the production of red blood cells (RBC). A new report on the global Erythropoietin Drug Market , published by Market Research Future (MRFR), estimates that this market can visualize expansion at 9.5% CAGR between 2017 and 2023. The most significant market driving factor for the global erythropoietin drug market growth is the increasing prevalence of diseases like cancer and various renal diseases. The increasing investment in medical research & development (R&D) and introduction of new drugs are also carrying forward the market growth. Noth just new drugs but the market is also getting strong due to the introduction of several new erythropoietin drug combinations. Other factors contributing to the global erythropoietin drug market growth include different government initiatives for research and a wi...